ROCKWELL MEDICAL, INC. Quarterly Debt-to-equity in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Rockwell Medical, Inc. quarterly Debt-to-equity history and growth rate from Q3 2018 to Q3 2024.
  • Rockwell Medical, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 125 %, a 39.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 125 -82.9 -39.8% Sep 30, 2024
Q2 2024 140 -103 -42.4% Jun 30, 2024
Q1 2024 165 -53.3 -24.4% Mar 31, 2024
Q4 2023 183 -151 -45.2% Dec 31, 2023
Q3 2023 208 -278 -57.2% Sep 30, 2023
Q2 2023 243 -361 -59.8% Jun 30, 2023
Q1 2023 218 -453 -67.4% Mar 31, 2023
Q4 2022 333 +18.6 +5.92% Dec 31, 2022
Q3 2022 486 +285 +142% Sep 30, 2022
Q2 2022 604 +458 +315% Jun 30, 2022
Q1 2022 671 +526 +362% Mar 31, 2022
Q4 2021 314 +162 +106% Dec 31, 2021
Q3 2021 201 +46.7 +30.3% Sep 30, 2021
Q2 2021 145 -20.1 -12.2% Jun 30, 2021
Q1 2021 145 +18.5 +14.6% Mar 31, 2021
Q4 2020 152 +41.1 +36.9% Dec 31, 2020
Q3 2020 154 +49 +46.7% Sep 30, 2020
Q2 2020 166 +46.6 +39.1% Jun 30, 2020
Q1 2020 127 -8.06 -5.98% Mar 31, 2020
Q4 2019 111 -5.62 -4.8% Dec 31, 2019
Q3 2019 105 -5.37 -4.87% Sep 30, 2019
Q2 2019 119 Jun 30, 2019
Q1 2019 135 Mar 31, 2019
Q4 2018 117 Dec 31, 2018
Q3 2018 110 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.